Sign Up for Updates
We are working to advance SURF303, our clinical study of dabogratinib for LG-UTUC. Please complete this form to receive updates.
"*" indicates required fields
This study is being conducted by Tyra Biosciences, Inc.
Tyra Biosciences, Inc., 2656 State Street, Carlsbad, CA 92008
© 2025 Tyra Biosciences, Inc. All Rights Reserved.